RESPULES • RESPULES

BUDERIO-0.5

Budesonide Nebuliser Suspension BP0.5mg/2ml respules

Schedule H Prescription Drug
Printed MRP: ₹499.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
4x5x2ml
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
BUDERIO-0.5 Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name BUDERIO-0.5
Active Formulation (Salt) Budesonide Nebuliser Suspension BP0.5mg/2ml respules
Dosage Form RESPULES
Packaging Presentation 4x5x2ml
Therapeutic Category RESPULES
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is BUDERIO-0.5?

Therapeutic monograph and clinical profile

BUDERIO-0.5 (Budesonide Nebuliser Suspension BP0.5mg/2ml respules) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 4x5x2ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Maintenance of Asthma / Croup (Laryngotracheobronchitis).

Key Formulation Highlights

Why healthcare professionals recommend BUDERIO-0.5

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Maintenance of Asthma / Croup (Laryngotracheobronchitis)

Pharmacological Mechanism of Action

How BUDERIO-0.5 acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for BUDERIO-0.5

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for BUDERIO-0.5 across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding BUDERIO-0.5

What is BUDERIO-0.5 used for?
BUDERIO-0.5 is prescribed for Maintenance of Asthma / Croup (Laryngotracheobronchitis). Always follow physician dosage instructions.
What is the printed packaging and MRP of BUDERIO-0.5?
The printed packaging is 4x5x2ml with an MRP of ₹499.00.
How can I get monopoly PCD franchise for BUDERIO-0.5?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.